Hepatoblastoma
Child hepatoblastoma risk heightened due to certain maternal and infant birth characteristics
Published in Clinical Oncology Week, July 10th, 2006
"Hepatoblastoma is a rare embryonal tumor with unknown etiology. The authors conducted a case-cohort study using public health surveillance data sets to examine perinatal risk factors for hepatoblastoma," scientists in the United States reported.
"Hepatoblastoma cases (n=58) diagnosed between 1985 and 2001 were identified from the New York State Cancer Registry and were matched to electronic birth records for 1985-2001 from New York State, excluding New York City. Controls (n=6,056) were selected from the birth cohorts for the same years. Having a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cholangiocarcinoma
Cholangiocarcinoma diagnosed early from examination of bile duct brushings - Acute Myeloid Leukemia
Acute myeloid leukemia managed on outpatient basis - Adenocarcinomas
High body mass index increases adenocarcinoma risk in the esophagus or gastric cardia - Adenocarcinomas
Primary adenocarcinomas of the small bowel not associated with Epstein-Barr virus infection - Adrenal Cortical Cancer
Case of adrenal cortical carcinoma metastatic to the breast reported - Adverse Drug Reaction
Cancer patients can develop enterocolitis after antibody blockade - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
